文献速递浆细胞疾病

尿液外泌体评估AL淀粉样变性患者肾脏反应的概念验证

Assessment of renal response with urinary exosomes in patients with AL amyloidosis: A proof of concept.
PubMed 文献 · Am J Hematol · 2017-05-04

本研究从一例已达完全缓解但肾脏病变仍进展的AL淀粉样变性患者中分离尿液外泌体,鉴定出免疫球蛋白轻链寡聚体,并通过质谱在外泌体和血清中识别出两种单克隆λ轻链,其中一种与肾脏淀粉样沉积的λ6轻链及浆细胞克隆的IGLV-6-57家族匹配。尿液外泌体质谱可识别现有临床方法无法检出的单克隆轻链,并鉴定出淀粉样变性轻链,未来可能用于疗效评估。

要点

  • 患者已达完全缓解但肾脏病变仍进展,尿液外泌体中仍可检出轻链寡聚体。
  • 尿液外泌体联合质谱识别出两种单克隆λ轻链,现有临床方法未能检出。
  • 鉴定出的淀粉样变性轻链与肾脏淀粉样沉积及浆细胞克隆序列匹配。

核心结论

  • 尿液外泌体联合质谱可识别现有临床方法无法检出的两种单克隆λ轻链。
  • 该方法还鉴定出淀粉样变性轻链,未来可能用于疗效评估。

研究设计与样本

  • 概念验证研究,从一例已达完全缓解但肾脏病变仍进展的AL淀粉样变性患者中分离尿液外泌体。
  • 采用质谱分析尿液外泌体和血清,并对肾脏激光显微切割获得的胰酶消化淀粉样片段进行蛋白质组学分析。
  • 对浆细胞克隆cDNA进行测序,与淀粉样肽氨基酸序列及外泌体和血清中轻链质量进行匹配。

主要发现

  • 尿液外泌体中鉴定出轻链寡聚体。
  • 尿液外泌体和血清质谱分析识别出两种单克隆λ轻链。
  • 肾脏淀粉样片段蛋白质组学分析鉴定出λ6轻链。
  • 浆细胞克隆cDNA属于IGLV-6-57家族,其氨基酸序列与淀粉样肽匹配。
  • cDNA预测肽产物质量与尿液外泌体和血清中两种轻链之一的质量匹配。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Immunoglobulin light chain (AL) amyloidosis is a fatal complication of B-cell proliferation secondary to deposition of amyloid fibrils in various organs. Urinary exosomes (UEX) are the smallest of the microvesicles excreted in the urine. Previously, we found UEX of patients with AL amyloidosis contained immunoglobulin light chain (LC) oligomers that patients with multiple myeloma did not have. To further explore the role of the LC oligomers, UEX was isolated from an AL amyloidosis patient with progressive renal disease despite achieving a complete response. LC oligomers were identified. Mass spectrometry (MS) of the UEX and serum identified two monoclonal lambda LCs. Proteomics of the trypsin digested amyloid fragments in the kidney by laser microdissection and MS analysis identified a λ6 LC. The cDNA from plasma cell clone was from the IGLV- 6-57 family and it matched the amino acid sequences of the amyloid peptides. The predicted mass of the peptide product of the cDNA matched the mass of one of the two LCs identified in the UEX and serum. UEX combined with MS were able to identify 2 monoclonal lambda LCs that current clinical methods could not. It also identified the amyloidogenic LC which holds potential for response assessment in the future.

来源:Am J Hematol,查看原文。版权归原作者所有。

引用

  1. Ramirez-Alvarado M, Barnidge DR, Murray DL, et al. Assessment of renal response with urinary exosomes in patients with AL amyloidosis: A proof of concept. Am J Hematol. 2017. PMID: 28295502. doi:10.1002/ajh.24717

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。